Cargando…
A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
Objective. To compare the effectiveness of a flexible multidose gonadotropin-releasing hormone (GnRH) antagonist against the effectiveness of a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to in vitro fertilization (IVF). Study Design...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487334/ https://www.ncbi.nlm.nih.gov/pubmed/26161425 http://dx.doi.org/10.1155/2015/970163 |
_version_ | 1782378989988347904 |
---|---|
author | Turgay Çelik, Gayem İnayet Sütçü, Havva Kömür Akpak, Yaşam Kemal Akar, Münire Erman |
author_facet | Turgay Çelik, Gayem İnayet Sütçü, Havva Kömür Akpak, Yaşam Kemal Akar, Münire Erman |
author_sort | Turgay Çelik, Gayem İnayet |
collection | PubMed |
description | Objective. To compare the effectiveness of a flexible multidose gonadotropin-releasing hormone (GnRH) antagonist against the effectiveness of a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to in vitro fertilization (IVF). Study Design. A retrospective study in Akdeniz University, Faculty of Medicine, Department of Obstetrics and Gynecology, IVF Center, for 131 poor responders in the intracytoplasmic sperm injection-embryo transfer (ICSI-ET) program between January 2006 and November 2012. The groups were compared to the patients' characteristics, controlled ovarian stimulation (COH) results, and laboratory results. Results. Combination protocol was applied to 46 patients (group 1), and a single protocol was applied to 85 patients (group 2). In group 1, the duration of the treatment was longer and the dose of FSH was higher. The cycle cancellation rate was significantly higher in group 2 (26.1% versus 38.8%). A significant difference was not observed with respect to the number and quality of oocytes and embryos or to the number of embryos transferred. There were no statistically significant differences in the hCG positivity (9.5% versus 9.4%) or the clinical pregnancy rates (7.1% versus 10.6%). Conclusion. The combination protocol does not provide additional efficacy. |
format | Online Article Text |
id | pubmed-4487334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44873342015-07-09 A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF Turgay Çelik, Gayem İnayet Sütçü, Havva Kömür Akpak, Yaşam Kemal Akar, Münire Erman Biomed Res Int Research Article Objective. To compare the effectiveness of a flexible multidose gonadotropin-releasing hormone (GnRH) antagonist against the effectiveness of a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to in vitro fertilization (IVF). Study Design. A retrospective study in Akdeniz University, Faculty of Medicine, Department of Obstetrics and Gynecology, IVF Center, for 131 poor responders in the intracytoplasmic sperm injection-embryo transfer (ICSI-ET) program between January 2006 and November 2012. The groups were compared to the patients' characteristics, controlled ovarian stimulation (COH) results, and laboratory results. Results. Combination protocol was applied to 46 patients (group 1), and a single protocol was applied to 85 patients (group 2). In group 1, the duration of the treatment was longer and the dose of FSH was higher. The cycle cancellation rate was significantly higher in group 2 (26.1% versus 38.8%). A significant difference was not observed with respect to the number and quality of oocytes and embryos or to the number of embryos transferred. There were no statistically significant differences in the hCG positivity (9.5% versus 9.4%) or the clinical pregnancy rates (7.1% versus 10.6%). Conclusion. The combination protocol does not provide additional efficacy. Hindawi Publishing Corporation 2015 2015-06-16 /pmc/articles/PMC4487334/ /pubmed/26161425 http://dx.doi.org/10.1155/2015/970163 Text en Copyright © 2015 Gayem İnayet Turgay Çelik et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Turgay Çelik, Gayem İnayet Sütçü, Havva Kömür Akpak, Yaşam Kemal Akar, Münire Erman A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF |
title | A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF |
title_full | A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF |
title_fullStr | A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF |
title_full_unstemmed | A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF |
title_short | A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF |
title_sort | flexible multidose gnrh antagonist versus a microdose flare-up gnrh agonist combined with a flexible multidose gnrh antagonist protocol in poor responders to ivf |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487334/ https://www.ncbi.nlm.nih.gov/pubmed/26161425 http://dx.doi.org/10.1155/2015/970163 |
work_keys_str_mv | AT turgaycelikgayeminayet aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT sutcuhavvakomur aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT akpakyasamkemal aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT akarmunireerman aflexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT turgaycelikgayeminayet flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT sutcuhavvakomur flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT akpakyasamkemal flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf AT akarmunireerman flexiblemultidosegnrhantagonistversusamicrodoseflareupgnrhagonistcombinedwithaflexiblemultidosegnrhantagonistprotocolinpoorresponderstoivf |